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Effect of aging on b-adrenergically mediated
thermogenesis in men
DANIE¨LLE A. J. M. KERCKHOFFS, ELLEN E. BLAAK,
MARLEEN A. VAN BAAK, AND WIM H. M. SARIS
Department of Human Biology, Maastricht University, 6200 MD Maastricht, The Netherlands
Kerckhoffs, Danie¨lle A. J. M., Ellen E. Blaak, Marleen
A. van Baak, and Wim H. M. Saris. Effect of aging on
b-adrenergically mediated thermogenesis in men. Am. J.
Physiol. 274 (Endocrinol. Metab. 37): E1075–E1079, 1998.—
The age-dependent alterations in b-adrenergically mediated
thermogenesis were investigated in 11 young (mean 6 SE
age: 21.9 6 0.5 yr) and 9 older (52.9 6 2.1 yr) men during
intravenous infusion of the nonselective b-agonist isoprena-
line (Iso). The older men had higher basal plasma norepineph-
rine (327.7 6 35.8 vs. 159.0 6 18.2 pg/ml, P , 0.001) and
epinephrine (75.1 6 18.1 vs. 29.1 6 5.3 pg/ml, P , 0.05)
concentrations than the young. The b-adrenergically medi-
ated thermogenesis was diminished in the older men, as
reflected by the significantly higher plasma Iso concentration
needed to increase resting energy expenditure by 15% (236.1 6
51.0 vs. 107.6 6 11.4 pg/ml, P , 0.05). Additionally, both dose
(39.4 6 6.6 vs. 19.1 6 1.5 ng·kg fat-free mass21 ·min21, P ,
0.01) and plasma concentration (332.2 6 59.1 vs. 119.3 6 14.0
pg/ml, P , 0.01) of Iso needed to increase resting heart rate by
25 beats/min were higher in older than in younger subjects,
suggesting that the age-related decline in b-adrenergic sensi-
tivity is a generalized defect not related to a specific tissue or
response. In conclusion, aging is associated with a diminished
b-adrenergically mediated thermogenesis. This blunted ther-
mogenic response may contribute to a positive energy balance
and thus promote increased fat storage and obesity.
energy expenditure; chronotropic response; age; sympathetic
nervous system; isoprenaline
AGING is associated with an increased risk for several
chronic diseases such as type 2 diabetes and cardiovas-
cular disease. A factor involved in the increased preva-
lence of these diseases may be the age-related change
in body composition that includes an increase in (ab-
dominal) fat mass and obesity (6), since both body fat
mass and abdominal fat distribution are risk factors in
the development of type 2 diabetes and cardiovascular
disease (11). To come to a more effective prevention or
treatment of the age-related increase in body fat stor-
age, more information is necessary on the responsible
mechanisms.
Aging may be associated with altered patterns of
energy expenditure (21). Several studies have demon-
strated that resting metabolic rate declines with advanc-
ing age (8, 16–19, 25). In most cases, the decrease in
age-related decline in fat-free mass seems to be the best
available predictor of the decrease in resting metabolic
rate. Furthermore, diet-induced thermogenesis (DIT)
may decline with aging. It is possible that this decline
plays a role in the increased adiposity found with
advancing age by promoting a positive energy balance.
Schwartz et al. (21) hypothesized that the reduction in
DIT is related to diminished activity of the sympathetic
nervous system. This is in accordance with numerous
studies that reported that aging is associated with
alterations in sympathetic activity. Despite the in-
creased basal sympathetic activity (4, 9, 17, 20, 21), as
reflected by a rise in circulating norepinephrine, there
appear to be blunted sympathetically mediated meta-
bolic responses with aging. Especially, a decline in
b-adrenergically mediated heart rate response in older
persons is well established (3, 7, 9, 26). At present, it is,
however, not known whether the sympathetically medi-
ated thermogenesis also declines with aging. If so, this
results in an increased efficiency of energy expenditure,
contributing thereby to the age-related increase in body
fat stores. Previous studies have shown that the
b-adrenoceptors are mainly involved in the sympatheti-
cally mediated thermogenesis (1). Thus, to obtain more
information on the mechanisms behind the age-related
increase in obesity, the present study was intended to
investigate whether the b-adrenergically mediated ther-
mogenesis is altered with aging.
METHODS
Subjects. Eleven young (21.9 6 0.5 yr) and 9 older (52.9 6
2.1 yr) men participated in this study after their written
informed consent was obtained (Table 1). The study protocol
was approved by the Ethics Committee of Maastricht Univer-
sity. The results of the young subjects have been previously
published (2). All subjects were normotensive and generally
in good health. Cardiovascular and/or respiratory diseases
were excluded by a medical questionnaire and physical
examination. Subjects participated no more than 3 h/wk in
sports activities, and none of the subjects had a physically
demanding job.
Body composition. Body density was measured by hydro-
static weighing, with a correction for residual lung volume as
determined by helium dilution (Volugraph 2000, Mijnhardt,
The Netherlands). Body composition was calculated accord-
ing to the formula of Siri (22).
Isoprenaline infusion test. To determine b-adrenergically
mediated thermogenic and heart rate (HR) responses, sub-
jects fasted overnight and came to the laboratory by car or
bus. The experiments were done in the morning in a quiet
room with a temperature between 23 and 25°C. The subjects
remained in a supine position throughout the study. Intrave-
nous catheters were inserted into both arms, one for infusion
of the nonselective b-agonist isoprenaline (Iso) and the other
for blood sampling.
After a 30-min rest period, Iso was infused in stepwise
increasing doses of 6, 12, and 24 ng·kg fat-free mass21 ·min21
for 30 min at each dose level. The dose is related to Iso sulfate,
69% of which corresponds to Iso free base. After the baseline
measurement and at the end of each infusion period, blood
was sampled with a heparinized syringe for plasma concentra-
tions of Iso, norepinephrine (NE), and epinephrine (Epi). The
sample was collected into a chilled tube containing glutathi-
one and immediately centrifuged at 3,000 rpm at 4°C. The
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plasma samples were stored at 280°C until concentrations of
Iso, NE, and Epi were determined by HPLC with electrochemi-
cal detection (23).
During the experiment, whole body energy expenditure
(EE) was determined by an open-circuit ventilated hood
system (Oxycon Beta, Mijnhardt, The Netherlands). A clear
Plexiglas ‘‘hood’’ was placed over the subject’s head and sealed
off by plastic straps around the neck. Air is sucked through
the hood with a pump and blown into a mixing chamber
where a sample is taken for analysis. The oxygen consump-
tion and the carbon dioxide production were estimated from
the total airflow and the oxygen and carbon dioxide concentra-
tions of the air flowing in and out. Total EE was calculated
according to the formula of Weir (27).
During the experiment, HR was monitored by continuous
electrocardiogram recording. When HR had increased by 30
beats/min, the Iso infusion was stopped.
b-Adrenergically mediated thermogenic and HR responses.
EE and HR responses of the young and older men reached a
steady state after 10 min of Iso infusion, i.e., 5-min values
were stable until the end of the infusion period. Therefore,
mean values over the last 20 min were considered as represen-
tative for the administered doses. The respiratory exchange
ratio (RER) in both groups reached a steady state after 20 min
of infusion after a rapid increase within the first 5 min of the
Iso infusion that was most probably caused by a change in
ventilation (1). Therefore, RER values over the last 10 min of
infusion were averaged.
To summarize the response of the subject to Iso infusion in
a single value (2), the b-adrenergically mediated thermogen-
esis was expressed as the dose or plasma concentration of Iso
required to increase resting EE (REE) by 15% (doseDEE515%
and concnDEE515%, respectively). To evaluate the b-adrenergi-
cally mediated HR responses, both the chronotropic dose
(CD25) and the chronotropic concentration (CC25) were
calculated from the dose and plasma concentration, respec-
tively, of Iso required to increase resting HR by 25 beats/min
(13). These values were determined by individual linear
regression of response vs. dose or plasma concentration of Iso.
Statistical analysis. Values are presented as means 6 SE.
Differences between the young and older groups were ana-
lyzed by use of Student’s unpaired t-test. The effects of Iso
infusion on various parameters within each group and be-
tween both groups were analyzed by use, respectively, of
one-factor and two-factor ANOVA for repeated measure-
ments. Simple and multiple regression analyses were used to
determine which variables contributed to variations in re-
sponse between subjects. A value of P , 0.05 was considered
significant.
RESULTS
Physical characteristics of the subjects are given in
Table 1. There is .30 yr of difference between the mean
ages of the young (n 5 11 subjects) and the older (n 5 9
subjects) groups. Although weight and body mass index
were similar in both groups, the older subjects had
significantly higher percent body fat compared with the
young (P , 0.05).
Figure 1 shows the changes in plasma Iso, NE, and
Epi with infusion of stepwise increasing doses of Iso in
young and older men. There were dose-dependent
increases in plasma Iso in both groups (for young and
older subjects: one-factor ANOVA for repeated measure-
ments, P , 0.001), but the mean plasma concentrations
with the increasing standardized doses were higher in
the older than in the young subjects (two-factor ANOVA
for repeated measurements, P , 0.05; Fig. 1A). Basal
values of plasma NE and Epi were significantly differ-
ent between young and older subjects (unpaired t-test:
NE, 159.0 6 18.2 vs. 327.7 6 35.8 pg/ml, P , 0.001; Epi,
29.1 6 5.3 vs. 75.1 6 18.1 pg/ml, P , 0.05, respectively;
Fig. 1, B and C). During Iso infusion, there was an
increase in plasma NE (for young and older subjects,
P , 0.001) and no significant change in plasma Epi in
both groups as illustrated in Fig. 1, B and C. Moreover,
the older men had higher mean plasma NE (P , 0.001)
and Epi (P , 0.05) concentrations with increasing
doses of Iso compared with the young subjects (Fig. 1, B
and C).
REE was not significantly different between young
and older subjects (Table 2). Figure 2 shows the changes
in EE (as %change above baseline), RER, and HR (as
%change) with infusion of stepwise increasing doses of
Iso in young and older men. The young and the older
subjects showed Iso-induced increases in EE (for both
groups, P , 0.001). There were no significant differ-
ences in the increases in EE with increasing doses of Iso
between the young and older groups, irrespective of
whether increases were expressed as percent increase
above baseline (Fig. 2A, P 5 0.30) or absolute increase
(young vs. older men: change in EE, 6 ng, 0.44 6 0.06
vs. 0.27 6 0.10 kJ/min; 12 ng, 0.70 6 0.08 vs. 0.51 6
0.06 kJ/min; 24 ng, 1.10 6 0.11 vs. 0.82 6 0.12 kJ/min,
respectively), although the absolute increases in EE
tended to be lower in the older men (P 5 0.08). In
addition, doseDEE515% was not significantly different
between groups, as indicated in Table 2. However,
when responses were related to plasma concentrations
of Iso, concnDEE515% was lower in the young than the
older men (Table 2), indicating a blunted b-adrenergi-
cally mediated thermogenic response in the older men.
Resting values of the RER were similar in young and
older subjects (0.81 6 0.01 vs. 0.82 6 0.01, respec-
tively). The RER decreased with higher doses of Iso in
the young (P , 0.001), whereas there was no significant
change in the older subjects. However, there were no
Table 1. Physical characteristics of subjects
Young (n511) Older (n59)
Age, yr 21.960.5 (20–25) 52.962.1† (45–62)
Weight, kg 73.963.5 (48.0–90.0) 72.262.9 (57.6–85.9)
Height, cm 181.562.1 (167.0–192.0) 173.762.8* (160.7–187.5)
Body mass
index,
kg/m2 22.360.8 (17.2–26.6) 23.960.6 (21.6–27.5)
%Body fat 11.961.1 (5.8–18.0) 16.961.9* (8.9–24.5)
Fat mass,
kg 9.161.2 (3.8–15.8) 12.261.5 (6.3–19.9)
Fat-free
mass, kg 64.862.6 (43.5–76.8) 60.062.6 (44.8–71.8)
Diastolic
BP,
mmHg 6462 (58–72) 8861† (80–95)
Systolic BP,
mmHg 12064 (98–136) 13962† (130–150)
Values are means 6 SE; ranges are in parentheses; n 5 no. of
subjects. BP, blood pressure. *P , 0.05, †P , 0.001 vs. young.
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significant differences in the RER with Iso between
young and older subjects (Fig. 2B).
The Iso-induced increases in HR of the young and
older subjects (for both groups, P , 0.001) were lower in
the older men than in the young (P , 0.01) when
related to the dose of Iso, either expressed as absolute
increase above baseline (CD25, Table 2) or as percent
change in HR (Fig. 2C). Basal HR levels were lower in
the young than in the older men (Table 2). HR re-
sponses to Iso expressed as CD25 and CC25 values are
shown in Table 2. Both CD25 and CC25 values were
lower in the young than in the older men. Thus the
older men also seem to have blunted b-adrenergically
mediated HR responses. Furthermore, there was a
significant correlation between Iso-induced thermo-
genic and HR response in both young (R 5 0.80, P ,
0.01) and older subjects (R 5 0.69, P , 0.05).
A multiple regression analysis with age and percent
body fat as independent variables and concnDEE515% and
CC25 as dependent variables showed that age was the
only factor significantly contributing to the variation in
concnDEE515% (multiple R 5 0.55, P , 0.05) and CC25
(multiple R 5 0.66, P , 0.01). This is confirmed in the
observation that exclusion of the lowest values of
percent body fat in the young and the highest values in
the older men resulted in two groups with comparable
percent body fat [young men (n 5 9) 13.2 6 0.9 vs. older
men (n 5 6) 13.6 6 1.4%] and a still lowered thermogen-
esis in the older men (concnDEE515%: young men 111.9 6
12.0 vs. older men 201.7 6 45.9 pg/ml; P 5 0.052).
DISCUSSION
The present study was undertaken to obtain more
information on the underlying mechanisms for the
age-related increase in body fat mass by investigating
whether the b-adrenergically mediated thermogenesis
was altered with aging. The main finding of the present
study was that the b-adrenergically mediated thermo-
genic response was diminished in the older men, as
reflected by the significantly higher concnDEE515%. This
blunted thermogenic response in the older men was not
statistically significant when the thermogenic response
was related to the administered standardized dose of
Iso per fat-free mass. In accordance with several stud-
ies (2, 10, 13), the above findings indicate that using
individual venous plasma Iso concentration-response
curves instead of dose-response curves increases the
precision of the Iso-infusion test, as interindividual
variations of plasma Iso pharmacokinetics between
individuals are taken into account. This is of special
importance in the comparison of groups with differ-
ences in age, since aging is associated with a reduced
Fig. 1. Changes in plasma isoprenaline (Iso; A), norepinephrine (NE;
B), and epinephrine (Epi; C) with infusion of stepwise increasing
doses of nonselective b-agonist Iso in young (k) and older (p) men.
Values are means 6 SE. FFM, fat-free mass. One-factor ANOVA for
repeated measurements: plasma Iso and NE, P , 0.001 for young and
older subjects. Two-factor ANOVA for repeated measurements: young
vs. older subjects, plasma Iso, P , 0.05; plasma NE, P , 0.001; and
plasma Epi, P , 0.05.
Table 2. REE, basal HR, and b-adrenergic sensitivity
in young and older men
Young (n511) Older (n59)
REE, kJ/min 5.660.2 5.160.3
Basal HR, beats/min 54.561.4 64.464.0*
DoseDEE515%, ng·kg
FFM21 ·min21 18.961.9 28.265.7
ConcnDEE515%, pg/ml 107.6611.4 236.1651.0*
CD25, ng·kg FFM21 ·min21 19.161.5 39.466.6†
CC25, pg/ml 119.3614.0 332.2659.1†
Values are means 6 SE; n 5 no. of subjects. REE, resting energy
expenditure; HR, heart rate; doseDEE515% and concnDEE515%, dose and
plasma concentration, respectively, of isoprenaline (Iso) needed to
increase resting energy expenditure by 15%; CD25 and CC25, dose
and concentration, respectively, of Iso needed to increase resting HR
by 25 beats/min. *P , 0.05, †P , 0.01 vs. young.
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clearance of drugs within the body, as also reflected by
the higher Iso concentrations in older men in the
present study during infusion of doses standardized for
fat-free mass. The diminished clearance has been re-
ported to be caused by decreases in hepatic metabolism
and renal elimination capacity (15).
Our data of a blunted thermogenic response with
advancing age seem to correspond with a previous
study of Schwartz et al. (21), who showed a reduced DIT
in older men. Our study is, however, the first to
demonstrate that a diminished b-adrenergic sensitivity
may be responsible for this blunted response. Because
of the fact that in the present study, percent body fat in
the older group was already slightly higher than in the
younger subjects, we cannot make a definite statement
on whether the impaired thermogenesis is a cause or a
consequence of the increased percent body fat. How-
ever, multiple regression analysis with age and percent
body fat as independent variables indicated that only
age significantly contributed to the variations in ther-
mogenic response, strongly indicating that in these
nonobese older men, the blunted thermogenesis is a
consequence of aging per se. This seems to correspond
to previous data showing that the Iso-induced thermo-
genesis is only blunted in obese subjects with a percent
body fat .30 (2). The age-related decrease in thermogen-
esis may contribute to the elevated percent body fat in
the older men and may thereby play an important role
in the increased risk for chronic diseases such as type 2
diabetes and coronary heart disease.
The exact mechanism for the decline in b-adrenergic
sensitivity remains to be determined. Basal plasma NE
concentrations were significantly higher in the older
subjects, reflecting an increase in basal sympathetic
activity, as previously reported (4, 9, 17, 20, 21). It is
possible that this increased basal plasma NE concentra-
tion in the older men may lead to a downregulation (24)
and decreased agonist binding of adrenoceptors (14,
24). Additionally, alterations in adrenoceptor density
(7, 9, 24) and postreceptor defects, such as changes in G
protein-mediated signal transduction (4, 5, 24) or in
activity of hormone-sensitive lipase (12), may probably
contribute to the blunted responses in the older men. It
is noteworthy that besides the decreased b-adrenergi-
cally mediated thermogenesis with aging, HR response
was also significantly blunted in the older men, as
reported before (3, 7, 9, 26). Moreover, there was a
significant positive relationship between b-adrenergi-
cally mediated thermogenic and HR responses in both
groups. These data suggest that the age-related de-
crease in b-adrenergic sensitivity is a generalized de-
fect not related to a specific organ or response. It
remains, however, to be elucidated whether the de-
crease in b-adrenergic sensitivity is caused by a de-
crease in sensitivity of all b-adrenoceptor subtypes or is
caused by a b-adrenoceptor subtype-specific decrease in
sensitivity.
During b-adrenergic stimulation, there was a signifi-
cant decrease in the RER in young but not in older men,
which may indicate a higher increase in fat oxidation
during b-adrenergic stimulation in the young subjects.
However, differences in the changes in RER with Iso
infusion between the two groups did not reach statisti-
cal significance.
In conclusion, b-adrenergically mediated thermo-
genic and HR responses are blunted in older persons
(45–62 yr) compared with a younger control group
(20–25 yr). The exact mechanism for this decrease in
sensitivity remains to be determined. The reduction in
the Iso-induced thermogenic response with age may
contribute to the increased percent body fat in the older
men and the related risk for chronic diseases such as
type 2 diabetes and cardiovascular disease. Further
Fig. 2. Changes in energy expenditure (EE, as %change; A), respira-
tory exchange ratio (RER; B) and heart rate (HR, as %change; C)
with infusion of stepwise increasing doses of nonselective b-agonist
Iso in young (k) and older (p) men. Values are means 6 SE.
One-factor ANOVA for repeated measurements: %change in EE and
HR, P , 0.001 for young and older subjects; RER, young men, P ,
0.001. Two-factor ANOVA for repeated measurements: young vs.
older subjects, %change in HR, P , 0.01.
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studies are necessary to elucidate the responsible
mechanisms for the age-related blunting of the thermo-
genic response.
This study was supported by grants from the Dutch Diabetes
Funds.
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